logo-loader

Zynerba Pharmaceuticals

Receive alerts
Market:
NASDAQ
Market Cap:
$198.81 m
Price
8.57 USD
Change
6.46%
52 weeks high
16.46
52 weeks low
2.82

In brief

At Zynerba Pharmaceuticals, our team is dedicated to developing next-generation transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. Often, these diseases have few, if any, treatment options and can leave patients and their families feeling helpless and alone. Zynerba is committed to developing breakthrough therapies to transform the quality of lives of patients and their families as they battle these conditions.

Deep dive We explore the investor case for growth companies

Snapshot

With top-line data from the CONNECT-FX trial on the way, investors are eyeing opportunities defined by marijuana-adjacent companies